Can I File a Byetta Lawsuit?
If you have used Byetta, you may be wondering whether you can file a lawsuit against the drug company. Byetta increases your risk of thyroid cancer, pancreas cancer, and pancreatitis, according to studies. Although this increase is unlikely, it does exist. To file a lawsuit against Byetta, you must retain an attorney who specializes in this type of litigation. To learn more about this lawsuit, read the article below.
Byetta increased the risk of pancreatic cancer
In 2007 the FDA issued an alert on Byetta and the increased risk of pancreatitis. In acute pancreatitis, patients can suffer from necrotizing or hemorrhagic pancreatitis. Acute pancreatitis requires medical attention and can result in hospitalization. Moreover, chronic pancreatitis increases the risk of pancreatic cancer and other health complications.
In the year 2013, the FDA addressed this issue regarding the possible link between Byetta and pancreatic cancer. In the study, researchers analyzed data from the FDA’s Adverse Event Reporting System to determine the extent of the increased risk. The findings indicated that Byetta users had a 2.9-fold increased risk of developing pancreatic cancer when compared with other diabetic drugs. The increased risk was linked to the drug’s use and the period between diagnosis and the start of Byetta’s use.
A study conducted in 2005 suggested a possible link between Byetta and pancreatitis, but the drug maker tried to downplay the connection. A new study published in the journal Gastroenterology, however, raised concerns about the drug’s side effects. Byetta can lead to asymptomatic pancreatitis and may lead to pancreatic cancer. That’s why doctors should pay close attention to the risks of Byetta before taking the drug.
Byetta increased risk of thyroid cancer
A new study published in the Gastroenterology journal in 2011 has found a possible link between Byetta and an increased risk of thyroid cancer. The study analyzed adverse event reports submitted to the Food and Drug Administration between 2004 and 2009. Despite the findings, the researchers say more studies are needed to establish a direct link between Byetta and thyroid cancer. Although the drug is a relatively new one, it has been associated with an increased risk of thyroid cancer.
The drug is also linked to pancreatitis and kidney problems. This drug was approved by the FDA to treat diabetes. If you have been diagnosed with the disease, contact a lawyer to evaluate your case. If you have been diagnosed with thyroid cancer, you may have a valid claim. Byetta is also linked to pancreatitis, an inflammation of the pancreas. Pancreatic cancer has a low survival rate.
The FDA required Byetta’s manufacturer to conduct six post-marketing studies to determine if the drug increased the risk of thyroid cancer. The results from the Gastroenterology study revealed that patients on Byetta had a 4.7-fold increased risk of developing the disease. Another study conducted at the University of California-San Francisco found that mice treated with Byetta had a 4.73-fold higher risk of developing thyroid cancer.
Byetta increased the risk of pancreatitis
Since being approved by the FDA in April 2005, Byetta has been linked to an increased risk of pancreatitis. Although the drug is effective at controlling blood sugar levels, it has been linked to an increased risk of pancreatitis, which is a potentially fatal condition. A study published in 2012 suggested that people who took exenatide had an increased risk of developing pancreatitis. The study also pointed to a lack of adequate warnings for doctors and patients.
The FDA issued an alert in the fall of 2007 warning that Byetta is associated with an increased risk of acute pancreatitis. The drugs can cause hemorrhagic and necrotizing pancreatitis, which require immediate medical care. Patients with either type of pancreatitis should stop taking the drug immediately and seek medical treatment. In addition to hospitalization, Byetta may also increase the risk of developing other health problems, including pancreatic cancer.
While Januvia and Byetta have been approved by the FDA for treating type 2 diabetes, recent discoveries suggest that the drugs may also increase the risk of pancreatic cancer. Both drugs increase the production of the hormone glucagon-like peptide-1 (GLP-1), which speeds up the development of pre-cancerous conditions in the pancreas. The FDA is currently evaluating these findings to see if they can be safely prescribed.